For decades, topical medications have been the default first-line treatment for glaucoma. However, the well-recognized challenges of daily eye drops, including poor adherence, ocular surface disease, fluctuating intraocular pressure (IOP), and long-term treatment, have fueled a significant transformation in glaucoma therapy. As a result, glaucoma management has undergone a fundamental shift towards laser-based solutions.